다중혈관 관상동맥 환자에서 y-문합을 이용하여 양쪽 내흉동맥만을 사용한 우회술의 조기 성적

Authors/Task Force Members: John J.V. McMurray (Chairperson) (UK)*, Stamatis Adamopoulos (Greece), Stefan D. Anker (Germany), Angelo Auricchio (Switzerland), Michael Böhm (Germany), Kenneth Dickstein (Norway), Volkmar Falk (Switzerland), Gerasimos Filippatos (Greece), Cândida Fonseca (Portugal), Miguel Angel Gomez-Sanchez (Spain), Tiny Jaarsma (Sweden), Lars Køber (Denmark), Gregory Y.H. Lip (UK), Aldo Pietro Maggioni (Italy), Alexander Parkhomenko (Ukraine), Burkert M. Pieske (Austria), Bogdan A. Popescu (Romania), Per K. Rønnevik (Norway), Frans H. Rutten (The Netherlands), Juerg Schwitter (Switzerland), Petar Seferovic (Serbia), Janina Stepinska (Poland), Pedro T. Trindade (Switzerland), Adriaan A. Voors (The Netherlands), Faiez Zannad (France), Andreas Zeiher (Germany).

ESC Guidelines for the Diagnosis And Treatment of Acute And Chronic Heart Failure 2008

ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2012 : The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC

https://anmco.it/uploads/u_cms/media/2014/12/798e9298d77b7b8c9aa0514e43fe95a2.pdf

ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC.

March 5, 2019 e1 WRITING GROUP MEMBERS Emelia J. Benjamin, MD, ScM, FAHA, Chair Paul Muntner, PhD, MHS, FAHA, Vice Chair Alvaro Alonso, MD, PhD, FAHA Marcio S. Bittencourt, MD, PhD, MPH Clifton W. Callaway, MD, FAHA April P. Carson, PhD, MSPH, FAHA Alanna M. Chamberlain, PhD Alexander R. Chang, MD, MS Susan Cheng, MD, MMSc, MPH, FAHA Sandeep R. Das, MD, MPH, MBA, FAHA Francesca N. Delling, MD, MPH Luc Djousse, MD, ScD, MPH Mitchell S.V. Elkind, MD, MS, FAHA Jane F. Ferguson, PhD, FAHA Myriam Fornage, PhD, FAHA Lori Chaffin Jordan, MD, PhD, FAHA Sadiya S. Khan, MD, MSc Brett M. Kissela, MD, MS Kristen L. Knutson, PhD Tak W. Kwan, MD, FAHA Daniel T. Lackland, DrPH, FAHA Tené T. Lewis, PhD Judith H. Lichtman, PhD, MPH, FAHA Chris T. Longenecker, MD Matthew Shane Loop, PhD Pamela L. Lutsey, PhD, MPH, FAHA Seth S. Martin, MD, MHS, FAHA Kunihiro Matsushita, MD, PhD, FAHA Andrew E. Moran, MD, MPH, FAHA Michael E. Mussolino, PhD, FAHA Martin O’Flaherty, MD, MSc, PhD Ambarish Pandey, MD, MSCS Amanda M. Perak, MD, MS Wayne D. Rosamond, PhD, MS, FAHA Gregory A. Roth, MD, MPH, FAHA Uchechukwu K.A. Sampson, MD, MBA, MPH, FAHA Gary M. Satou, MD, FAHA Emily B. Schroeder, MD, PhD, FAHA Svati H. Shah, MD, MHS, FAHA Nicole L. Spartano, PhD Andrew Stokes, PhD David L. Tirschwell, MD, MS, MSc, FAHA Connie W. Tsao, MD, MPH, Vice Chair Elect Mintu P. Turakhia, MD, MAS, FAHA Lisa B. VanWagner, MD, MSc, FAST John T. Wilkins, MD, MS, FAHA Sally S. Wong, PhD, RD, CDN, FAHA Salim S. Virani, MD, PhD, FAHA, Chair Elect On behalf of the American Heart Association Council on Epidemiology and Prevention Statistics Committee and Stroke Statistics Subcommittee

Heart Disease and Stroke Statistics—2019 Update: A Report From the American Heart Association

ALAT
: alanine aminotransferase
ASAT
: aspartate aminotransferase
APAH
: associated pulmonary arterial hypertension
BAS
: balloon atrial septostomy
BMPR2
: bone morphogenetic protein receptor 2
BNP
: brain natriuretic peptide
BPA
: balloon pulmonary angioplasty
BREATHE
: Bosentan

/pdf/2015-esc-ers-guidelines-for-the-diagnosis-and-treatment-of-y26yabnnom.pdf

2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension: The Joint Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS): Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC), International Society for Heart and Lung Transplantation (ISHLT).

Arrhythmogenic left ventricular apical aneurysm in hypertrophic cardiomyopathy

Purpose: To evaluate the long time outcome with regard to local tumour control and side effects of a pulsed dose rate (PDR) monobrachytherapy of primary or recurrent cancer of the lip. Material and methods: Between 1995 and 2007 we treated 43 patients with primary or recurrent clinical T1-T3N0 lip cancers. There were 22 T1 patients (51%), 16 T2 (37%) and 5 T3 cases (12%). A median dose of 60 (55-66) Gy was given, depending on the tumour volume. The PDR treatment was delivered with 0.83 Gy/pulse every second hour for 5.5-6.5 days. The patients were followed for a median of 55 (1-158) months. Results: The 2-, 5- and 10-year rates of actuarial local control were 97.6%, 94.5% and 94.5%, overall survival 88.0%, 58.9% and 39.1%, disease free survival 92.7%, 86.4% and 86.4% respectively. The regional control rate was 93%. One patient (2%) developed distant metastases. A dosimetrical analysis showed a mean treated volume of 14.9 (3.0-56.2) cm 3 . Long-term side effects were mild and the cosmetic outcome excellent, except for 1 case (2%) of soft tis sue necrosis and 1 case (2%) of osteoradionecrosis. Conclusions: Local outcome is excellent and similar to other published studies of continuous low dose rate (cLDR) brachytherapy.

https://www.termedia.pl/Journal/-54/pdf-16921-10?filename=Long term results.pdf

Long term results of PDR brachytherapy for lip cancer.

The Effect of Valve Strategy on In-Cylinder Flow and Combustion

Partially Premixed Combustion (PPC) is a promising advanced combustion mode for future engines In order to investigate the sensitivity of PPC to exhaust gas recirculation (EGR) rate, intake gas temperature, intake gas pressure, and injection timing, these parameters were swept individually at three different loads in a single cylinder diesel engine with gasoline-like fuelA factor of sensitivity was defined to indicate the combustion's controllability and sensitivity to inlet gas parameters and injection timings Through analysis of experimental results, a control window of inlet gas parameters and injection timings is obtained at different loads in PPC mode from 5 bar to 10 bar IMEPg load at 1200 rpmTo further study the PPC controllability with injection timing, main injection timing was adjusted to sustain steady combustion phasing subject to perturbation of inlet gas state Experimental results show that the main injection timing can resist the interference of intake parameters and maintain constant combustion phasing Injection timing control is a promising approach to maintain high engine efficiency and low emission levels during transient operation (Less)

Sensitivity Analysis of Partially Premixed Combustion (PPC) for Control Purposes

Partially Premixed Combustion (PPC) is a promising combustion concept with high thermodynamic efficiency and low emission level, and also with minimal modification of standard engine hardware. To use PPC in a production oriented engine, the optimal intake charge conditions for PPC should be included in the analysis. The experiments in this paper investigated and confirmed that the optimal intake conditions of net indicated efficiency for PPC are EGR between 50% and 55% as possible and the lambda close to 1.4. Heat-transfer energy and exhaust gas waste-energy contribute to the majority of the energy loss in the engine. The low EGR region has high heat-transfer and low exhaust gas enthalpy-waste, while the high EGR region has low heat-transfer and high exhaust gas waste-enthalpy. The optimal EGR condition is around 50% where the smallest energy loss is found as a trade-off between heat transfer and exhaust-gas enthalpy-waste. Lambda close to 1.4 results from the trade-off of high gas-exchange efficiency with low lambda and high thermodynamic efficiency with high lambda. The optimal inlet charge condition was also applied to a multi-cylinder engine from low load to high load. The results indicate that the highest net indicated efficiency of the experimental engine was 49.7% at 13.5 bar IMEPn (Net Indicated Mean Effective Pressure), the highest brake efficiency was 44.2% observed at 17.2 bar IMEPn. (Less)

Bengt Johansson

Papers

Arrhythmogenic left ventricular apical aneurysm in hypertrophic cardiomyopathy

Long term results of PDR brachytherapy for lip cancer.

The Effect of Valve Strategy on In-Cylinder Flow and Combustion

Sensitivity Analysis of Partially Premixed Combustion (PPC) for Control Purposes

An Experimental Investigation of a Multi-Cylinder Engine with Gasoline-Like Fuel towards a High Engine Efficiency